Adoptive therapies based on CAR/TCR T cells—that is, T cells with an engineered chimeric antigen receptor (CAR) or a T-cell receptor (TCR)—have shown promise for a range of cancers, offering hope to ...

GenScript is delighted to announce its 4th Annual Virtual Summit on Gene and Cell Engineering. This event will feature leading experts from academia, pharma, and biotech, showcasing the transformative ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...

Portal Biotechnologies and Multiply Labs announced a collaboration with the goal of leveraging automation to accelerate product timelines and reduce costs, helping innovative cell therapies reach more ...

UBC research associate Dr. Ross Jones in the lab where they are working to develop cell-based therapies from stem cells. Credit: Phillip Chin. For the first time, researchers at the University of ...